InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-24.8%
Across 5 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Harris Matthew Scott, Directeur Médical. Officer active across 1 company, notably Altimmune, Inc.. Aggregated, 17 filings have been published. Breakdown: 1 buy · 0 sell. Total volume traded: €39k. History available since 31 July 2021. The latest transaction was filed on 7 March 2025 (Don). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations17 total
67,787 shares0Common Stock, par value $0.0001SEC:0001104659-25-022550:0
9,275 shares0Common Stock, par value $0.0001SEC:0001104659-25-008772:0
14,600 shares0Common Stock, par value $0.0001SEC:0001104659-25-006841:0
4,994 shares@ US$6.9818.2% of flowCommon Stock, par value $0.0001SEC:0001104659-25-006841:1
1,486 shares@ US$5.414.0% of flowCommon Stock, par value $0.0001SEC:0001104659-24-084991:0
6,166 shares0Common Stock, par value $0.0001SEC:0001104659-24-010779:0
9,275 shares0Common Stock, par value $0.0001SEC:0001104659-24-009540:0
691 shares@ US$2.811.0% of flowCommon Stock, par value $0.0001SEC:0001104659-23-086905:0
10,000 shares@ US$4.2221.1% of flowCommon Stock, par value $0.0001SEC:0001104659-23-036172:0
Ideal exit: 18 Dec 2023 (T+270)
7,775 shares0Common Stock, par value $0.0001SEC:0001104659-23-011211:0
1,296 shares@ US$10.20856.6% of flowCommon Stock, par value $0.0001SEC:0001104659-23-009974:0
1,076 shares@ US$6.863.9% of flowCommon Stock, par value $0.0001SEC:0001104659-22-085624:0
30,000 shares@ US$1.92130.0093% mcap62.0% of flowCommon Stock, par value $0.0001SEC:0001104659-22-029462:0
1,800 shares@ US$6.860.0020% mcap13.3% of flowCommon Stock, par value $0.0001SEC:0001104659-22-011519:0
1,800 shares@ US$6.866.0% of flowCommon Stock, par value $0.0001SEC:0001104659-22-011519
725 shares@ US$7.70950.0008% mcap5.7% of flowCommon Stock, par value $0.0001SEC:0001104659-21-101663:0
725 shares@ US$7.70952.6% of flowCommon Stock, par value $0.0001SEC:0001104659-21-101663
17 of 17 declarations
About Harris Matthew Scott
Matthew Scott Harris is the Chief Medical Officer at Altimmune, Inc. He is responsible for leading medical and research initiatives. Matthew plays a key role in developing new treatments and improving patient outcomes.
